Lemtrada (alemtuzumab) injection is approved for the management of relapsing forms of multiple sclerosis (MS). In general, use of Lemtrada should be limited to patients with MS who have not had therapeutic success with 2 or more prior treatments.
March 2015
Advertisement
Advertisement
Trending on HCPLive
1
Interim Phase 3 VISIONARY Data Show Sibeprenlimab Preserved Kidney Function in IgA Nephropathy
2
Trials and Guidelines Shaping Critical Care, With Rhea Votipka, NP
3
Navigating a New Era of PH Management as an APP, With Susanne McDevitt, DNP
4
First Half 2026 Recap: Dermatology
5